Literature DB >> 25481053

CT and radiographic appearance of extracranial Onyx(®) embolization.

J B Jia1, C S Green2, A J Cohen2, M Helmy2.   

Abstract

Onyx(®) (ev3, Irvine, CA, USA) is a liquid embolic agent composed of ethylene vinyl alcohol copolymer dissolved in dimethyl sulphoxide used for the treatment of intracranial arteriovenous malformations. Onyx is a preferred embolizing agent due to its unique properties, non-adhesive nature, and durability. In addition to its approved intracranial application, Onyx is also being used successfully in extracranial embolization in areas including extracranial aneurisms and vascular malformations, trauma, gastrointestinal bleeding, and neoplasms. Because of its increasing utilization, it is important for reporting radiologists to be able to recognize its extracranial appearance across different imaging techniques and to be familiar with its uses. The goal of this review is to describe the extracranial uses of Onyx and its appearance in various extracranial locations at radiography and CT, while providing didactic examples. Onyx appears radiodense at CT and plain radiography and has a curvilinear pattern following the expected path of the vessel embolized. At CT, Onyx creates streak artefact that may obstruct the view of surrounding tissues consistent with descriptions of other tantalum devices.
Copyright © 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25481053     DOI: 10.1016/j.crad.2014.10.019

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  2 in total

1.  Iterative metal artifact reduction in aortic CTA after Onyx®-embolization.

Authors:  Leena Lehti; Marcus Söderberg; Helena Mellander; Johan Wassélius
Journal:  Eur J Radiol Open       Date:  2020-09-04

2.  Preparation and investigation of a novel iodine-based visible polyvinyl alcohol embolization material.

Authors:  Yupeng Yang; Rui Yang; Beilei Zhang; Ye Tian; Yanqi Lu; Xiao An; Xiangyang Shi
Journal:  J Interv Med       Date:  2022-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.